Colectomy — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Colectomy is the surgical removal of a segment or the entirety of the large intestine (colon). It is classified by extent: partial colectomy removes a defined colon segment (right hemicolectomy, transverse colectomy, left hemicolectomy, or sigmoid colectomy), total colectomy removes the entire colon from the ileocaecal junction to the rectosigmoid junction, and total proctocolectomy removes both the colon and rectum. Following resection, bowel continuity is restored by anastomosing the divided ends — for example, connecting the ileum to the transverse colon after right hemicolectomy. When anastomosis is unsafe due to bowel inflammation, contamination, or compromised blood supply, a temporary or permanent stoma (ileostomy or colostomy) is created. Laparoscopic colectomy using 4–5 small port incisions has largely replaced open surgery at high-volume centres, offering equivalent oncological clearance with lower wound complication rates, shorter hospital stay, and faster recovery. Robotic-assisted colectomy is an emerging technique offering improved ergonomics and visualisation in complex pelvic dissections. Total mesorectal excision (TME) is the standard surgical technique for rectal cancer, ensuring en bloc removal of the rectum and its surrounding mesorectal envelope containing lymph nodes. Enhanced Recovery After Surgery (ERAS) pathways have transformed colorectal surgery outcomes, enabling early feeding, mobilisation, and discharge.

Colectomy is indicated for a range of benign and malignant conditions. Colorectal cancer is the most common indication, requiring segmental or total resection with appropriate proximal vessel ligation for adequate lymph node clearance. Complicated diverticular disease — including diverticular abscess (Hinchey III, IV), fistula formation, stricturing, or recurrent symptomatic attacks — is a major benign indication, with elective sigmoid colectomy being curative. Inflammatory bowel disease including ulcerative colitis refractory to medical therapy or complicated by dysplasia or cancer is treated by total proctocolectomy, which is curative for UC. Crohn's colitis affecting a defined segment may be treated by limited resection though not curative. Familial adenomatous polyposis (FAP) and MUTYH-associated polyposis with multiple colorectal polyps require prophylactic total or subtotal colectomy to prevent inevitable cancer development. Acute bowel obstruction from cancer, volvulus, or adhesions requiring emergency decompression, ischaemic colitis with transmural necrosis or bowel gangrene, and refractory lower gastrointestinal haemorrhage complete the urgent indications. Minimally invasive approaches are applied electively; emergency cases typically require open surgery.

The patient is positioned supine or in modified lithotomy (for sigmoid or rectal surgery) under general anaesthesia with epidural or spinal analgesia. Laparoscopic colectomy begins with port placement: a 10–12 mm camera port at the umbilicus and 3–4 working ports at strategic abdominal locations. The targeted colon segment is mobilised by sequential division of peritoneal attachments and mesenteric vessels using an energy sealing device, with the main feeding artery (ileocolic, middle colic, inferior mesenteric, or sigmoid arteries) ligated at its origin for oncological resection. The mobilised colon is extracted through a small 5–7 cm wound protected by a wound retractor, divided using a linear stapler, and the specimen removed. An anastomosis is fashioned using a circular stapling device (for colorectal anastomoses) or sutured hand-sewn technique, and leak-tested by insufflating air with the anastomosis submerged in saline. A temporary defunctioning loop ileostomy may be fashioned if the anastomosis is at high risk of leak — low anastomoses within 5 cm of the anal verge, cases with adverse patient factors, or emergency surgery. The abdomen is irrigated and fascial and skin wounds closed. Operative time is 2–4 hours for laparoscopic cases and up to 4–6 hours for complex pelvic dissections. Robotic-assisted platforms offer enhanced visualisation and ergonomics during complex pelvic dissections.

For colorectal cancer, radical colectomy with adequate margins and lymph node harvest is the only curative treatment, with 5-year survival rates of 90% for Stage I, 70–80% for Stage II, 40–65% for Stage III (with adjuvant chemotherapy), and 5–15% for Stage IV disease treated with metastasectomy and chemotherapy. Total colectomy for ulcerative colitis is definitively curative — removing the diseased mucosa eliminates the risk of colitis-related cancer and the systemic inflammatory burden, with most patients reporting dramatic improvement in quality of life after recovery. For FAP patients, prophylactic colectomy averts the near-certain development of colorectal cancer by age 40. Laparoscopic colectomy compared with open surgery reduces wound infection rates from approximately 10% to 3%, reduces hospital stay by 1–2 days, and accelerates return to work and normal activity by 1–2 weeks while maintaining equivalent oncological clearance. Enhanced recovery after surgery protocols have reduced post-operative ileus duration, opioid requirements, and overall hospital length of stay from 8–10 days to 3–5 days for laparoscopic right colectomy.

Anastomotic leak is the most feared specific complication, occurring in 2–5% of colonic anastomoses and up to 10–15% for very low rectal anastomoses. It presents with fever, abdominal pain, and sepsis on days 3–7 post-operatively and may require re-exploration, anastomotic take-down, and stoma formation. Wound infection affects 3–10% depending on the bowel preparation status and laparoscopic versus open approach. Post-operative ileus is universal to some degree and is prolonged (more than 5 days) in 5–10%; managed conservatively with enhanced recovery measures including early oral feeding and mobilisation. Deep vein thrombosis and pulmonary embolism require prophylaxis with low-molecular-weight heparin and compression stockings. Ureteral injury occurs in less than 1% and is higher in pelvic dissections for rectal cancer or complex diverticular disease with inflammation. Autonomic pelvic nerve injury during rectal dissection can cause bladder dysfunction (urinary retention in 5–15%) and sexual dysfunction (erectile dysfunction in 20–30% of men, retrograde ejaculation in 10–20%). Incisional hernia rates are 5–10% for laparoscopic and 15–20% for open approaches at 5 years.

Enhanced Recovery After Surgery (ERAS) protocols now guide post-operative care: patients receive clear oral fluids the evening of surgery and progress to soft diet on day 1–2. Nasogastric tubes and drains are removed early — typically on day 1 — unless specific indications exist. Urinary catheters are removed at 24–48 hours, earlier for laparoscopic right colectomy. Mobilisation starts on the day of surgery with physiotherapist assistance. Epidural or spinal analgesia is maintained for 24–48 hours then transitioned to oral analgesia. Hospital discharge is typically 3–5 days for laparoscopic colectomy and 5–7 days for open. Bowel function returns within 1–4 days (first flatus) and 2–5 days (first bowel motion). The bowel pattern normalises over 4–8 weeks; softer, more frequent stools are common temporarily, particularly after right hemicolectomy. Stoma patients receive specialist stoma nurse education before and after surgery. Return to desk work is at 4–6 weeks, manual labour at 8–12 weeks. Driving resumes when the patient can perform an emergency stop comfortably — typically 4–6 weeks. Activity restriction includes no lifting over 5 kg for 6 weeks to prevent incisional hernia. Oncology follow-up includes 3-monthly CEA measurements and CT scans at 12 and 36 months for cancer cases.